Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.

Citation:
Hassan Metwally, M. A., R. Ali, M. Kuddu, T. Shouman, P. Strojan, J. Overgaard, and C. Grau, "Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.", Acta oncologica (Stockholm, Sweden), vol. 54, issue 9, pp. 1673-7, 2015.